Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, placebo-controlled trial in patients with type 2 diabetes mellitus inadequately controlled with diet and exercise
Potential Benefits and Risks of Microdosing GLP-1 Microdosing GLP-1 is proposed to reduce dose-dependent gastrointestinal side effects such as nausea and vomiting, but lacks randomised controlled trial evidence for efficacy or safety
Peaks all-in price runs about $165 a month on the six-month plan with no separate medication bill, while Ro charges a $145 monthly membership plus medication (around $199 for Wegovy pen, or $345-plus total)
However, opponents argue maintaining wide access to the drugs produces greater savings by reducing obesity rates and lowering the risk of related conditions like heart disease
Gastroenterology 141, 150156 (2011)
Vitamin D deficiency is associated with sarcopenia in older Koreans, regardless of obesity: the Fourth Korea National Health and Nutrition Examination Surveys (KNHANES IV) 2009